Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: Oxytocin Treatment of Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial evaluating oxytocin as a treatment for schizophrenia, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Paranoia, Schizophrenia | NA | Status: COMPLETED | Results posted: 2017-04-18